Brief: Kaken Pharmaceutical gets domestic manufacture and marketing approval for periodontium regeneration medicine
28/09/2016 08:26
Sept 28 (Reuters) - Kaken Pharmaceutical Co Ltd 4521.T :
* Says it received domestic manufacture and marketing
approval for a periodontium regeneration medicine
Source text in Japanese:https://goo.gl/oVWgZq
Further company coverage: 4521.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 10 62674724;
Reuters Messaging: jun.cao.reuters.com@reuters.net))